Ge-68 / Ga-68 generator is a device for the radioactive decay of the long-lived main isotope Ge-68, which has a half-life of 271 days, and a positron-emitting Ga-68 isotope with a short half-life of 68 minutes.
In prostate cancer imaging, the tissue area contained by the tumor (cancerous tissue spread in the prostate) is used specifically for prostate cancer to show whether there is cancer spread to the lymph nodes or bones. It is recommended to be used to determine the localization of prostate cancer recurrence in the biochemical recurrence of prostate cancer (ie when PSA starts to rise again). It is especially recommended to show the place of recurrence in PSA values with increased PSA values between 0.4-10 ng / ml.
ESTROTEP (18F-Fluoroestradiol) is a radiopharmaceutical medicinal product with a role in the
diagnostic strategy for patients with metastatic, initially oestrogen receptor-positive (ER+) breast
cancer in early relapse following treatment with hormone therapy, when biopsy is deemed to be
impossible and an hormone therapy line can be envisaged.
EstroTep is approved in France, investigational use only in other countries.
I-124 as (PET) radiopharmaceutical, improving the diagnosis and treatment of differentiated thyroid cancers in current clinical practice has potential. Compared with standard gamma scintigraphy, PET / computed tomography has high sensitivity and Its spatial resolution can aid in the detection of recurrence or metastatic disease, and the greater can ensure accurate measurement.
The positron emitting isotope 89Zr is an ideal radiolabel for
PET imaging of monoclonal antibodies (mAbs).
Many researchers use 89Zr labeling with small animal immuno-PET to assess the targeting of mAbs in preclinical studies
Ac-225 is a radiochemical for research use only . The solution is used for the preparation of radiolabeled compounds in the non-clinical research concept.
Due to the short range of alpha particles in tissue
(<0.1 mm) due to selectively high tumor cells when radiation doses are applied to the surrounding tissues,
minimum damage is done. Thanks to this high
achieving treatment efficacy and reducing beta radiation
It can also be applied in cases with resistance
Lu-177 is a low-energy beta-particle emitter that works by directly irradiating cancer cells after being delivered to the cancer site by a targeting molecule. Lu-177 is used to treat neuroendocrine cancers. It also shows promise for the treatment of metastatic prostate and other cancers.
Bi-213 is a radiochemical for research use only . The solution is used for the preparation of radiolabeled compounds in the non-clinical research concept.
Y-90 is a radiochemical for research use only . The solution is used for the preparation of radiolabeled compounds in the non-clinical research concept.
We provide three separate benchtop imagers or “CUBES”. The γ-CUBE (SPECT), β-CUBE (PET) and X-CUBE (CT) are perfectly suited for in vivo multimodal whole body rat and mouse imaging. User-friendliness and expert servicing with no compromise on image quality is what we stand for.
We offer PET SPECT cameras.
We offer synthesis units for manufacturing of different radipharmaceuticals including but not limited to F18- (FDG,NaF,FLT,CHoline,MISO,FES,FET) and Ga68(DOTATOC,DOTATATE,PSMA)
Hotcells for radiopharmaceutical manufacting plants and radioactive working cabinets at hospitals
High standart quality control equipment for nuclear medicine industry
Radition monitoring and protection solutions for nuclear medicine applications